Lok Sabha Question No. 5045 (UNSTARRED), answered on 2022-04-01
Subject: Pharmaceutical Industry
Ministry: CHEMICALS AND FERTILIZERS
Asked by: Pritam Gopinath Munde, Girish Bhalchandra Bapat, Chandra Sekhar Sahu, Rahul Ramesh Shewale

## GOVERNMENT OF INDIA MINISTRY OF CHEMICALS & FERTILIZERS DEPARTMENT OF PHARMACEUTICALS

LOK SABHA UNSTARRED QUESTION No. 5045

TO BE ANSWERED ON THE 1 st  APRIL, 2022

## Pharmaceutical Industry

## 5045.   DR. PRITAM GOPINATHRAO MUNDE: SHRI GIRISH BHALCHANDRA BAPAT: SHRI CHANDRA SEKHAR SAHU: SHRI RAHUL RAMESH SHEWALE:

Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:

- (a) whether the Government has recently issued any guidelines for the scheme for strengthening of Pharmaceutical Industry in the country;
- (b) if so, the details thereof along with the details of funds allocated for the said scheme;
- (c) whether the Government also proposes to improve the existing infrastructural facilities of the pharma sector in the country;
- (d) if so, the details thereof along with the targets fixed by the Government under the said scheme; and
- (e) the steps taken to establish India a global leader in the pharma sector?

## ANSWER

## MINISTER OF STATE IN THE MINISTRY OF CHEMICALS & FERTILIZERS (SHRI BHAGWANTH KHUBA)

(a) & (b): The Department has recently issued the guidelines of the scheme 'Strengthening of Pharmaceutical Industry (SPI) in 11 th March 2022 with the following objectives:

-  To strengthen the existing infrastructure facilities in order to make India a global leader in the Pharma Sector by providing Financial assistance to pharma clusters for creation of Common Facilities.
-  To  upgrade  the  production  facilities  of  SMEs  and  MSMEs,  to  meet  national  and international regulatory standards, by providing interest subvention or capital subsidy on their capital loans.
-  To promote knowledge and awareness about the Pharmaceutical and Medical Devices Industry by taking up studies, building databases and brining industry leaders, academia and policy makers together to share their knowledge and experience.

The total financial outlay of the scheme is Rs. 500 crore for a period of five years from 2021-22 to 2025-26.

(c) to (e): Department of Pharmaceuticals strives to improve the infrastructural facilities of the pharma sector in the country towards making India, a global leader in the sector.

-  In  order  to  make  the  country  Atmanirbhar  in  pharmaceuticals,  the  Department  of Pharmaceuticals  has  launched  the  Production  Linked  Incentives  (PLI)  Scheme  for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/Drug Intermediates (DIs), and Active Pharmaceuticals Ingredients (APIs) in India. The Total financial outlay of the scheme is Rs. 6,940 crore and the tenure from FY 2020-2021 to FY-2029-30.
-  Another  'Production  Link  Incentive  (PLI)  scheme  for  Pharmaceuticals  has  been launched with total financial outlay of Rs. 15,000 crore and tenure from FY 2020-2021 to FY 2028-29. The scheme intends to enhance India's manufacturing capabilities by increasing  investment  and  production  in  the  sector  and  contributing  to  product diversification to high value goods in pharmaceuticals sector. The eligible drugs under this scheme include APIs among other categories of pharmaceuticals products.
-  The  Department  has  launched  a  scheme  to  provide  further  support  to  API  pharma companies through providing, financial assistance to the States for establishing three Bulk Drug Parks.
-  Further,  Department  provides  support  to  the  pharma  clusters  for  creating  common infrastructure  facilities  under  Assistance  to  Pharmaceuticals  Industry  for  Common Facilities (API-CF).
-  Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) has also been approved  to  support  SME  units  in  pharmaceutical  sector  for  quality  &  technology upgradation.

Details of all the above schemes can be accessed at https://pharmaceuticals.gov.in/schemes .

*****